tiprankstipranks
Trending News
More News >
Actinogen Medical Limited (AU:ACW)
ASX:ACW
Australian Market

Actinogen Medical (ACW) Ratios

Compare
36 Followers

Actinogen Medical Ratios

AU:ACW's free cash flow for Q4 2025 was AU$1.00. For the 2025 fiscal year, AU:ACW's free cash flow was decreased by AU$ and operating cash flow was AU$-1.27. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
3.76 3.76 13.91 7.04 13.80
Quick Ratio
3.76 3.76 13.91 7.04 13.80
Cash Ratio
2.77 2.77 6.96 4.70 11.06
Solvency Ratio
-2.34 -2.34 -7.82 -5.74 -5.81
Operating Cash Flow Ratio
-1.27 -1.27 -12.49 -4.83 -6.43
Short-Term Operating Cash Flow Coverage
-2.51 -2.51 -279.38 0.00 0.00
Net Current Asset Value
AU$ 16.28MAU$ 16.28MAU$ 17.26MAU$ 10.89MAU$ 18.85M
Leverage Ratios
Debt-to-Assets Ratio
0.13 0.13 0.01 <0.01 <0.01
Debt-to-Equity Ratio
0.18 0.18 0.02 <0.01 <0.01
Debt-to-Capital Ratio
0.15 0.15 0.02 <0.01 <0.01
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.34 1.34 1.08 1.13 1.07
Debt Service Coverage Ratio
-4.91 -3.12 -148.33 -622.33 -491.27
Interest Coverage Ratio
-305.42 -305.42 -528.53 -956.27 -712.89
Debt to Market Cap
0.02 0.04 <0.01 0.00 0.00
Interest Debt Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
0.88 0.88 0.41 0.55 1.27
Profitability Margins
Gross Profit Margin
96.31%100.00%100.00%91.70%88.99%
EBIT Margin
-279.70%-279.70%-133.47%-319.64%-360.40%
EBITDA Margin
-273.48%-273.48%-226.90%-311.34%-349.40%
Operating Profit Margin
-272.01%-272.01%-129.28%-324.74%-361.90%
Pretax Profit Margin
-268.37%-268.37%-231.34%-319.98%-360.91%
Net Profit Margin
-268.37%-268.37%-131.34%-219.98%-260.91%
Continuous Operations Profit Margin
-268.37%-168.37%-131.34%-219.98%-260.91%
Net Income Per EBT
100.00%100.00%56.77%68.75%72.29%
EBT Per EBIT
98.66%98.66%178.95%98.53%99.73%
Return on Assets (ROA)
-60.18%-60.18%-61.21%-70.70%-40.75%
Return on Equity (ROE)
-69.65%-80.35%-66.23%-80.20%-43.69%
Return on Capital Employed (ROCE)
-80.62%-80.62%-64.34%-118.39%-60.35%
Return on Invested Capital (ROIC)
-69.13%-43.37%-36.31%-80.87%-43.48%
Return on Tangible Assets
-64.90%-64.90%-67.88%-83.99%-46.14%
Earnings Yield
-11.53%-21.50%-9.23%-15.13%-11.22%
Efficiency Ratios
Receivables Turnover
0.95 0.95 1.07 1.26 0.92
Payables Turnover
0.22 0.00 0.70 0.37 0.45
Inventory Turnover
0.00 0.00 0.00 405.61K 400.67K
Fixed Asset Turnover
20.33 20.33 29.08 43.37 21.54
Asset Turnover
0.22 0.22 0.47 0.32 0.16
Working Capital Turnover Ratio
0.29 0.32 0.70 0.33 0.22
Cash Conversion Cycle
-1.28K 385.41 -180.57 -701.17 -423.45
Days of Sales Outstanding
385.41 385.41 342.41 290.02 395.28
Days of Inventory Outstanding
0.00 0.00 0.00 <0.01 <0.01
Days of Payables Outstanding
1.66K 0.00 522.97 991.20 818.73
Operating Cycle
385.41 385.41 342.41 290.02 395.28
Cash Flow Ratios
Operating Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Free Cash Flow Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
CapEx Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
1.01 1.01 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
-198.73 -198.73 -2.08K -237.66 -3.24K
Capital Expenditure Coverage Ratio
-198.73 -198.73 -2.08K -237.66 -3.24K
Operating Cash Flow Coverage Ratio
-2.31 -2.31 -53.13 -100.06 -57.59
Operating Cash Flow to Sales Ratio
-1.38 -1.38 -1.71 -1.78 -2.61
Free Cash Flow Yield
-5.69%-11.08%-12.00%-12.29%-11.24%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
-8.67 -4.65 -10.83 -6.61 -8.92
Price-to-Sales (P/S) Ratio
24.32 12.48 14.23 14.54 23.26
Price-to-Book (P/B) Ratio
6.97 3.74 7.18 5.30 3.90
Price-to-Free Cash Flow (P/FCF) Ratio
-17.58 -9.03 -8.33 -8.14 -8.89
Price-to-Operating Cash Flow Ratio
-16.91 -9.07 -8.34 -8.17 -8.90
Price-to-Earnings Growth (PEG) Ratio
-0.09 0.25 -2.06 -0.88 -0.09
Price-to-Fair Value
6.97 3.74 7.18 5.30 3.90
Enterprise Value Multiple
-8.01 -3.68 -5.87 -4.12 -5.38
Enterprise Value
120.26M 55.30M 132.20M 62.70M 68.48M
EV to EBITDA
-8.01 -3.68 -5.87 -4.12 -5.38
EV to Sales
21.91 10.07 13.31 12.83 18.81
EV to Free Cash Flow
-15.84 -7.28 -7.80 -7.18 -7.19
EV to Operating Cash Flow
-15.92 -7.32 -7.80 -7.21 -7.19
Tangible Book Value Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Shareholders’ Equity Per Share
<0.01 <0.01 <0.01 <0.01 0.01
Tax and Other Ratios
Effective Tax Rate
0.00 0.37 0.43 0.31 0.28
Revenue Per Share
<0.01 <0.01 <0.01 <0.01 <0.01
Net Income Per Share
>-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Tax Burden
1.00 1.00 0.57 0.69 0.72
Interest Burden
0.96 0.96 1.73 1.00 1.00
Research & Development to Revenue
2.24 2.24 1.56 1.82 2.26
SG&A to Revenue
0.37 0.37 0.17 0.37 0.37
Stock-Based Compensation to Revenue
0.30 0.00 0.00 0.31 0.35
Income Quality
0.51 0.00 1.30 0.81 1.00
Currency in AUD